PregLem
About:
PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for
Website: http://www.preglem.com
Top Investors: Sofinnova Partners, Sofinnova Investments, MVM Life Science Partners, Neomed Management
Description:
PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine.
Total Funding Amount:
68M CHF
Headquarters Location:
Geneva, Geneve, Switzerland
Founded Date:
2006-01-01
Contact Email:
info(AT)preglem.com
Founders:
Eric Rolin, Ernest Loumaye
Number of Employees:
11-50
Last Funding Date:
2007-12-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai